Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density

CONTEXT: In the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly – Pivotal Fracture Trial (HORIZON-PFT), zoledronic acid (ZOL) 5 mg significantly reduced fracture risk. OBJECTIVE: The aim of the study was to identify factors associated with greater efficacy during ZOL 5 mg trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Eastell, Richard, Black, Dennis M., Boonen, Steven, Adami, Silvano, Felsenberg, Dieter, Lippuner, Kurt, Cummings, Steven R., Delmas, Pierre D., Palermo, Lisa, Mesenbrink, Peter, Cauley, Jane A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5101059/
https://ncbi.nlm.nih.gov/pubmed/19567517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2008-2765
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados